Home › Neurologic Diseases › North Carolina
Neurologic Diseases clinical trials in North Carolina
7 studies for Neurologic Diseases are looking for participants at sites in North Carolina.
Cities in North Carolina
Product Surveillance Registry
- Chapel Hill
- Charleston
- Durham
- and 3 more
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Chapel Hill
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 15, 2026 · NCT06916806A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #067, Raleigh
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Denver, North Carolina, Denver
- Huntersville, North Carolina, Huntersville
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Sep 11, 2026 · NCT07598708A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Duke University, Durham
RecruitingPhase 1
Ages 50 to 85 · All sexes · Updated Aug 24, 2026 · NCT06297590Rett Syndrome Registry
- The University of North Carolina at Chapel Hill, Chapel Hill
RecruitingObservational study
Ages 0 to 99 · All sexes · Updated Jun 30, 2026 · NCT05432349Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Matthews
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.